- 2025-09-26 10:58Pim-1 kinase inhibitor 6 2928606-69-1
- 2025-09-26 10:58TLR8 agonist 2 hydrochloride 2412937-65-4
- 2025-09-26 10:58EGFR-IN-1 TFA 2753348-63-7
- 2025-09-26 10:58Angoline 21080-31-9
- 2025-09-26 10:58Pim-1 kinase inhibitor 5 2928606-67-9
- 2025-09-26 10:58TLR8 agonist 2 2412937-64-3
- 2025-09-26 10:58EGFR T790M/L858R-IN-2
- 2025-09-26 10:58(R)-Lisofylline ((R)-Lisophylline) 100324-81-0
- 2025-09-26 10:58Pim-1 kinase inhibitor 4 3026670-71-0
- 2025-09-26 10:58Cucurbitacin E 18444-66-1
- 2025-09-26 10:58TLR7agonist 15 2832199-53-6
- 2025-09-26 10:58EGFR Protein Tyrosine Kinase Substrate 945830-38-6
- 2025-09-26 10:58Ropsacitinib (PF-06826647; Tyk2-IN-8) 2127109-84-4
- 2025-09-26 10:58Pim-1 kinase inhibitor 3 2801695-39-4
- 2025-09-26 10:58TLR7/8/9-IN-1 2180127-82-4
- 2025-09-26 10:58EGFR mutant-IN-2 2770009-06-6
- 2025-09-26 10:58Pim-1 kinase inhibitor 2 2543624-91-3
- 2025-09-26 10:58Deucravacitinib (BMS-986165) 1609392-27-9
- 2025-09-26 10:58TLR7/8/9 antagonist 2 2920729-91-3
- 2025-09-26 10:58EGFR mutant-IN-1
